# PUMA BIOTECHNOLOGY INC (PBYI)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/PBYI/

- Reporting holders: 4
- Reported value: $29.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $16.8K | 1,693 | 0.0% | 4 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $10.9K | 1,094 | 0.0% | 5 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $1.8K | 186 | 0.0% | 1 |
| [ELEVATION WEALTH PARTNERS, LLC](https://holderbook.com/funds/1976256-elevation-wealth-partners-llc/) | $30 | 3 | 0.0% | 13 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $29.6K |
| Q2 2026 | 163 | $329.8M |
| Q1 2026 | 157 | $242.7M |
| Q4 2025 | 155 | $210.9M |
| Q3 2025 | 139 | $184.4M |
| Q2 2025 | 123 | $113.1M |
| Q1 2025 | 119 | $90.2M |
| Q4 2024 | 114 | $90.3M |
| Q3 2024 | 101 | $73.0M |
| Q2 2024 | 98 | $97.4M |
| Q1 2024 | 96 | $169.2M |
| Q4 2023 | 82 | $110.3M |